Literature DB >> 16638166

Risk factors for Salmonella Enteritidis and Typhimurium (DT104 and non-DT104) infections in The Netherlands: predominant roles for raw eggs in Enteritidis and sandboxes in Typhimurium infections.

Y Doorduyn1, W E Van Den Brandhof, Y T H P Van Duynhoven, W J B Wannet, W Van Pelt.   

Abstract

Since 1996 Salmonella Typhimurium DT104 salmonellosis has increased in The Netherlands. This prompted a case-control study of risk factors for salmonellosis to inform transmission routes for this phage type. Cases were laboratory-confirmed patients with a Salmonella infection and controls were selected from population registries by frequency matching for age, sex, degree of urbanization and season. Cases and controls received a questionnaire on risk factors. Of the 1171 cases, 573 (49%) responded: 245 S. Enteritidis and 232 S. Typhimurium cases (both DT104 and non-DT104), of which 58 were DT104. Of the 10250 controls, 3409 (33%) responded. Use of H2 antagonists [odds ratio (OR) 4.4, 95% CI 1.6-12.2] and proton pump inhibitors (OR 4.2, 95% CI 2.2-7.9), consumption of raw eggs (OR 3.1, 95% CI 1.3-7.4) and products containing raw eggs (OR 1.8, 95% CI 1.1-3.0) were associated with endemic S. Enteritidis infection. Risk factors for endemic S. Typhimurium infection were use of proton pump inhibitors (OR 8.3, 95% CI 4.3-15.9), occupational exposure to raw meat (OR 3.0, 95% CI 1.1-7.9), playing in a sandbox (for children aged 4-12 years) (OR 2.4, 95% CI 1.6-3.7), consumption of undercooked meat (OR 2.2, 95% CI 1.1-4.1) and use of antibiotics (OR 1.9, 95% CI 1.0-3.4). Use of proton pump inhibitors (OR 11.2, 95% CI 3.9-31.9) and playing in a sandbox (OR 4.4, 95% CI 1.8-10.7) were the only risk factors for S. Typhimurium DT104 salmonellosis. This study confirms known risk factors for salmonellosis. However, playing in a sandbox was a predominant new risk factor for S. Typhimurium salmonellosis in children [population attributable risk (PAR) 14%], and especially for S. Typhimurium DT104 (PAR 32%).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16638166      PMCID: PMC2870426          DOI: 10.1017/S0950268805005406

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  34 in total

Review 1.  A critical look at methods for handling missing covariates in epidemiologic regression analyses.

Authors:  S Greenland; W D Finkle
Journal:  Am J Epidemiol       Date:  1995-12-15       Impact factor: 4.897

2.  An outbreak of Salmonella typhimurium DT104 food poisoning associated with eating beef.

Authors:  A Davies; P O'Neill; L Towers; M Cooke
Journal:  Commun Dis Rep CDR Rev       Date:  1996-10-11

3.  Risk factors for sporadic salmonellosis in Switzerland.

Authors:  H Schmid; A P Burnens; A Baumgartner; J Oberreich
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-09       Impact factor: 3.267

4.  Emergence of multidrug-resistant Salmonella enterica serotype typhimurium DT104 infections in the United States.

Authors:  M K Glynn; C Bopp; W Dewitt; P Dabney; M Mokhtar; F J Angulo
Journal:  N Engl J Med       Date:  1998-05-07       Impact factor: 91.245

5.  Recent treatment with H2 antagonists and antibiotics and gastric surgery as risk factors for Salmonella infection.

Authors:  K R Neal; S O Briji; R C Slack; C J Hawkey; R F Logan
Journal:  BMJ       Date:  1994-01-15

6.  What do negative associations between potential risk factors and illness in analytical epidemiological studies of infectious disease really mean?

Authors:  Louise Swift; Paul R Hunter
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

7.  Chicken consumption is a newly identified risk factor for sporadic Salmonella enterica serotype Enteritidis infections in the United States: a case-control study in FoodNet sites.

Authors:  Akiko C Kimura; Vasudha Reddy; Ruthanne Marcus; Paul R Cieslak; Janet C Mohle-Boetani; Heidi D Kassenborg; Suzanne D Segler; Felicia P Hardnett; Timothy Barrett; David L Swerdlow
Journal:  Clin Infect Dis       Date:  2004-04-15       Impact factor: 9.079

8.  Role of egg consumption in sporadic Salmonella enteritidis and Salmonella typhimurium infections in Minnesota.

Authors:  C W Hedberg; M J David; K E White; K L MacDonald; M T Osterholm
Journal:  J Infect Dis       Date:  1993-01       Impact factor: 5.226

9.  A case control study of infection with an epidemic strain of multiresistant Salmonella typhimurium DT104 in England and Wales.

Authors:  P G Wall; D Morgan; K Lamden; M Ryan; M Griffin; E J Threlfall; L R Ward; B Rowe
Journal:  Commun Dis Rep CDR Rev       Date:  1994-10-14

10.  Multidrug-resistant strains of Salmonella enterica Typhimurium, United States, 1997-1998.

Authors:  Therese Rabatsky-Ehr; Jean Whichard; Shannon Rossiter; Ben Holland; Karen Stamey; Marcia L Headrick; Timothy J Barrett; Frederick J Angulo
Journal:  Emerg Infect Dis       Date:  2004-05       Impact factor: 6.883

View more
  53 in total

Review 1.  Case-control studies of sporadic enteric infections: a review and discussion of studies conducted internationally from 1990 to 2009.

Authors:  Kathleen E Fullerton; Elaine Scallan; Martyn D Kirk; Barbara E Mahon; Frederick J Angulo; Henriette de Valk; Wilfrid van Pelt; Charmaine Gauci; Anja M Hauri; Shannon Majowicz; Sarah J O'Brien
Journal:  Foodborne Pathog Dis       Date:  2012-04       Impact factor: 3.171

2.  Novel insight in the association between salmonellosis or campylobacteriosis and chronic illness, and the role of host genetics in susceptibility to these diseases.

Authors:  Y Doorduyn; W Van Pelt; C L E Siezen; F Van Der Horst; Y T H P Van Duynhoven; B Hoebee; R Janssen
Journal:  Epidemiol Infect       Date:  2007-12-07       Impact factor: 2.451

3.  Microbes in Beach Sands: Integrating Environment, Ecology and Public Health.

Authors:  Richard Whitman; Valerie J Harwood; Thomas A Edge; Meredith Nevers; Muruleedhara Byappanahalli; Kannappan Vijayavel; João Brandão; Michael J Sadowsky; Elizabeth Wheeler Alm; Allan Crowe; Donna Ferguson; Zhongfu Ge; Elizabeth Halliday; Julie Kinzelman; Greg Kleinheinz; Kasia Przybyla-Kelly; Christopher Staley; Zachery Staley; Helena M Solo-Gabriele
Journal:  Rev Environ Sci Biotechnol       Date:  2014-09-01       Impact factor: 8.044

Review 4.  Clinical Implications of Emerging Data on the Safety of Proton Pump Inhibitors.

Authors:  Felice Schnoll-Sussman; Philip O Katz
Journal:  Curr Treat Options Gastroenterol       Date:  2017-03

5.  Etiology of acute gastroenteritis in children requiring hospitalization in the Netherlands.

Authors:  I H M Friesema; R F de Boer; E Duizer; L M Kortbeek; D W Notermans; O F Norbruis; D D L Bezemer; H van Heerbeek; R N J van Andel; J G van Enk; P L A Fraaij; M P G Koopmans; A M D Kooistra-Smid; Y T H P van Duynhoven
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-03       Impact factor: 3.267

Review 6.  A benefit-risk assessment of the use of proton pump inhibitors in the elderly.

Authors:  Gwen M C Masclee; Miriam C J M Sturkenboom; Ernst J Kuipers
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

Review 7.  Proton-pump inhibitors: understanding the complications and risks.

Authors:  Peter Malfertheiner; Arne Kandulski; Marino Venerito
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-20       Impact factor: 46.802

8.  Association between recent use of proton pump inhibitors and nontyphoid salmonellosis: a nested case-control study.

Authors:  Hau-Hsin Wu; Yung-Tai Chen; Chia-Jen Shih; Yi-Tzu Lee; Shu-Chen Kuo; Te-Li Chen
Journal:  Clin Infect Dis       Date:  2014-08-04       Impact factor: 9.079

9.  Inhibition of lysosomal enzyme activities by proton pump inhibitors.

Authors:  Wensheng Liu; Susan S Baker; Jonathan Trinidad; Alma L Burlingame; Robert D Baker; John G Forte; Lauren P Virtuoso; Nejat K Egilmez; Lixin Zhu
Journal:  J Gastroenterol       Date:  2013-03-12       Impact factor: 7.527

Review 10.  Host-pathogen interactions in Campylobacter infections: the host perspective.

Authors:  Riny Janssen; Karen A Krogfelt; Shaun A Cawthraw; Wilfrid van Pelt; Jaap A Wagenaar; Robert J Owen
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.